A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients

Journal:

Kidney International

Published:

2025-05-23

DOI:

10.1016/j.kint.2025.04.023

Affiliations:

22

Authors:

16

Go to article

Institutions	Authors	Share
Monash University, Australia	5.000000	0.31
Monash Medical Centre (MMC), Australia	4.333333	0.27
Monash Health, Australia	2.000000	0.13
Austin Health, Australia	0.833333	0.05
The University of Sydney (USYD), Australia	0.833333	0.05
The University of Melbourne (UniMelb), Australia	0.500000	0.03
Sir Charles Gairdner Hospital (SCGH), Australia	0.500000	0.03
The University of Western Australia (UWA), Australia	0.500000	0.03
Royal Prince Alfred Hospital (RPAH), USYD, Australia	0.500000	0.03
Eastern Health, Australia	0.333333	0.02
Children's Hospital at Westmead (CHW), USYD, Australia	0.333333	0.02
Westmead Hospital (WSLHD), Australia	0.333333	0.02

Interested in Immunology?